Back
Aurinia Pharmaceuticals Quote, Financials, Valuation and Earnings
Sponsored
AUPH
Sponsored
Election Shock on August 19th?
Click here now to see the evidence I've gathered.
Buy
52
AUPH
Aurinia Pharmaceuticals
Last Price:
5.18
Seasonality Move:
3.33%
7 Day Trial
ALL ACCESS PASS
$
7
America's Final Republican President
Click here to see his 2024 election prediction.Aurinia Pharmaceuticals Price Quote
$5.18
+0.01 (+0.58%)
(Updated: May 10, 2024 at 6:10 AM ET)
Aurinia Pharmaceuticals Key Stats
Buy
52
Aurinia Pharmaceuticals (AUPH)
is a Buy
Day range:
$5.10 - $5.21
52-week range:
$4.71 - $12.43
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
4.21
P/B ratio:
1.96%
Volume:
691.1K
Avg. volume:
1.4M
1-year change:
-53.82%
Market cap:
$739.8M
Revenue:
$175.5M
EPS:
$-0.53
How Much Does Aurinia Pharmaceuticals Make?
-
How Much Are Aurinia Pharmaceuticals's Sales Annually?
AUPH Revenues are $175.5M -
How Much Profit Does Aurinia Pharmaceuticals's Make A Year?
AUPH net income is -$78M
Is Aurinia Pharmaceuticals Growing As A Company?
-
What Is Aurinia Pharmaceuticals's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.59% -
What Is Aurinia Pharmaceuticals's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Aurinia Pharmaceuticals Stock Price Performance
-
Did Aurinia Pharmaceuticals Stock Go Up Last Month?
Aurinia Pharmaceuticals share price went up by 1.22% last month -
Did AUPH's Share Price Rise Over The Last Year?
AUPH share price fell by -53.82% over the past 1 year
What Is Aurinia Pharmaceuticals 52-Week High & Low?
-
What Is Aurinia Pharmaceuticals’s 52-Week High Share Price?
Aurinia Pharmaceuticals has traded as high as $12.43 over the past 52 weeks -
What Is Aurinia Pharmaceuticals’s 52-Week Low Share Price?
Aurinia Pharmaceuticals has traded as low as $4.71 over the past 52 weeks
Aurinia Pharmaceuticals Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Aurinia Pharmaceuticals?
-
How Much Debt Does Aurinia Pharmaceuticals Have?
Total long term debt quarterly is $0 -
How Much Cash Does Aurinia Pharmaceuticals Have?
Cash and short term investments quarterly total is $350.5M -
What Is Aurinia Pharmaceuticals’s Book Value Per Share?
Book value per share is 2.63
Is Aurinia Pharmaceuticals Cash Flow Positive?
-
What Is AUPH Cash Flow From Operations?
Cash flow from operations (TTM) is -$33.5M -
What Is Aurinia Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$5.1M -
What Is Aurinia Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$6.7M
Aurinia Pharmaceuticals Return On Invested Capital
-
Is Management Doing A Good Job?
AUPH return on invested capital is -19.92% -
What Is Aurinia Pharmaceuticals Return On Assets?
ROA measures how assets are converting to revenues and is -15.15% -
What Is AUPH Return On Equity?
ROE is a measure of profitability and is -19.92%
Aurinia Pharmaceuticals Earnings Date & Stock Price
-
What Is Aurinia Pharmaceuticals's Stock Price Today?
A single share of AUPH can be purchased today for 5.17 -
What Is Aurinia Pharmaceuticals’s Stock Symbol?
Aurinia Pharmaceuticals trades on the nasdaq under the ticker symbol: AUPH -
When Is Aurinia Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for Aurinia Pharmaceuticals is scheduled on August 2, 2024 -
When Is AUPH's next ex-dividend date?
Aurinia Pharmaceuticals's next ex-dividend date is July 16, 2020 -
How To Buy Aurinia Pharmaceuticals Stock?
You can buy Aurinia Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Aurinia Pharmaceuticals Competitors
-
Who Are Aurinia Pharmaceuticals's Competitors?
Below is a list of companies who compete with Aurinia Pharmaceuticals or are related in some way:
Aurinia Pharmaceuticals Dividend Yield
Data Unavailable
Aurinia Pharmaceuticals Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 48.78% |
Revenue: | 58.59% | 6.86% |
Analyst Recommendations
Buy Recommendations: | 3 |
---|---|
Hold Recommendations: | 1 |
Sell Recommendations: | 0 |
Price Target: | 10.14 |
Upside from Last Price: | 96.09% |